Scientific article
Letter
Polatuzumab vedotin and CD79B : A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma
Published inBritish journal of haematology, vol. 207, no. 6, p. 2550-2552
Publication date2025-12
First online date2025-10-07
Keywords
- CD79B
- DLBCL
- R‐CHOP
- Antibody–drug conjugate
- Disulfiram
- Loncastuximab tesirine
- Lymphoma
- Polatuzumab vedotin
Research groups
Funding
- Swiss National Science Foundation - NCCR RNA & disease: The role of RNA biology in disease mechanisms (phase II) [182880]
- Swiss National Science Foundation - NCCR RNA & disease: The role of RNA biology in disease mechanisms (phase III) [205601]
- Swiss National Science Foundation - Enhancer RNAs in B cell lymphomas [197466]
Citation (ISO format)
MUNZ, Nicolas et al. Polatuzumab vedotin and CD79B : A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma. In: British journal of haematology, 2025, vol. 207, n° 6, p. 2550–2552. doi: 10.1111/bjh.70185
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:194561
- DOI : 10.1111/bjh.70185
- PMID : 41057281
- PMCID : PMC12710110
Journal ISSN0007-1048
